Amid Steep Rise In Mpox Cases, Vaccination Drive In Africa Becomes More Urgent [Forbes]
Emergent BioSolutions Inc. (EBS)
Last emergent biosolutions inc. earnings: 4/30 04:08 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.emergentbiosolutions.com
Company Research
Source: Forbes
AFP via Getty Images The first doses of an Mpox vaccine called Jynneos arrived this week in the Democratic Republic of Congo. Authorities expect more than 250,000 doses to be delivered to the DRC in the coming days. Given the current steep rise in cases, it's critical that sufficient supplies of vaccine are shipped to the DRC and other African countries and administered to the population at risk as soon as possible. In the past week alone there have been suspected new cases of Mpox (formerly known as monkeypox) in Africa, predominantly in the DRC, according to the Dutch news site NOS. Figures from CDC Africa show that 26 more people died from MPox last week. It's estimated that since the beginning of this year at least 25,000 people have been infected with Mpox, though in light of very limited access to diagnostic testing across Africa only a relatively small fraction has been confirmed. Since January, 643 people have died from the virus. The World Health Organization declare
Show less
Read more
Impact Snapshot
Event Time:
EBS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EBS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EBS alerts
High impacting Emergent BioSolutions Inc. news events
Weekly update
A roundup of the hottest topics
EBS
News
- Emergent BioSolutions Inc (EBS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]Yahoo! Finance
- Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024 [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions Inc. (NYSE: EBS) had its price target raised by analysts at Benchmark Co. from $8.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa [Yahoo! Finance]Yahoo! Finance
EBS
Earnings
- 11/6/24 - Beat
EBS
Sec Filings
- 11/8/24 - Form SC
- 11/7/24 - Form 10-Q
- 11/6/24 - Form 8-K
- EBS's page on the SEC website